MedTrace Logo

Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution

NCT03255187 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2024-04-23

Study results available
· View outcomes & findings →

Summary

This study aims to evaluate whether dietary supplementation with fish oil can protect against the cardiopulmonary alterations linked to air pollution

Conditions

  • Oxidative Stress
  • Inflammation
  • Blood Pressure
  • Vasoconstriction
  • Coagulation
  • Pulmonary Function

Interventions

DIETARY_SUPPLEMENT

Fish oil supplementation

Participants of this randomized double-blind placebo-controlled trial include 70 healthy Chinese adults. The investigators randomly assign participants to two parallel groups at baseline using a random-number table. Compliance is determined by directly observed supplement intake. Participants in fish oil group are assigned to receive 2.5 g/day in divided doses. Each capsule contains 60% n-3 PUFA \[24% docosahexanoic acid (C22:6 n-3 DHA) and 36% eicosapentaenoic acid (C20:5 n-3 EPA)\].

DIETARY_SUPPLEMENT

Sunflower seed oil supplementation

Participants of this randomized double-blind placebo-controlled trial include 70 healthy Chinese adults. The investigators randomly assign participants to two parallel groups at baseline using a random-number table. Compliance is determined by directly observed supplement intake. Participants in sunflower seed oil group receive 2.5 g/day in divided doses, and the capsules are identical as the fish oil capsules.

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Haidong Kan · School of Public Health，Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
27 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-09
Primary Completion
2018-01-13
Completion
2018-01-13

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03255187 on ClinicalTrials.gov